Results for tag: "Metastatic Liver Cancer Drug"

The Metastatic Liver Cancer Drug market is a subset of the larger Oncology Drugs market. It is composed of drugs used to treat metastatic liver cancer, a form of cancer that has spread from its original site to the liver. These drugs are used to reduce the size of tumors, slow the growth of cancer cells, and reduce symptoms. Common treatments include chemotherapy, targeted therapy, and immunotherapy. The Metastatic Liver Cancer Drug market is highly competitive, with many companies offering innovative treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck, Pfizer, Roche, and Novartis. Other companies such as AstraZeneca, Eli Lilly, and Amgen are also active in the market. Show Less Read more